Cefpodoxime Proxetil & Potassium Clavulanate Tablets – Potent Shield Against Resistant Bacterial Infections.
VANTIL CL Tablet: The composition of Cefpodoxime 200 mg + Clavulanic Acid 125 mg is formulated to treat moderate to severe bacterial infections. Cefpodoxime acts by inhibiting bacterial cell wall synthesis, while Clavulanic Acid neutralizes β-lactamase enzymes, preventing drug resistance. The synergy extends coverage to β-lactamase-producing organisms, improving therapeutic outcomes in difficult-to-treat infections.
Recommended bY Specialists:
✅General Physicians: It is mainly used to prefer this combination to upper and lower respiratory tract infections, urinary tract infections (UTIs)
✅Pulmonologists: It is mainly used to prefer to treat the combination of bronchitis, community-acquired pneumonia, and sinusitis.
Key Benefits of Cefpodoxime Proxetil & Potassium Clavulanate Tablets – VANTIL CL
✅Broad-Spectrum Activity with β-Lactamase Inhibition – Cefpodoxime, a 3rd-generation cephalosporin, targets gram-positive and gram-negative pathogens, while Clavulanic acid inhibits β-lactamase enzymes, restoring efficacy against resistant strains.
✅Enhanced Efficacy in Respiratory and Urinary Infections – Effective against common pathogens causing ENT, lower respiratory tract, and UTI infections, even those with partial resistance.
✅Improved Clinical Outcomes in Recurrent or Complicated Infections – Dual mechanism ensures a higher bacterial eradication rate and reduced treatment failures in chronic and resistant cases.
INDICATIONS:
✅Upper & Lower Respiratory Tract Infections
✅ENT Infections (Sinusitis, Otitis Media)
✅Urinary Tract Infections
✅Skin & Soft Tissue Infections
✅Gynecological Infections